We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
Illumina
ILMN
$40.5B
| $182K | ﹤0.01% |
1,319
+60
| +5% | +$6.92K |
2023 Q2
2 quarters
|
|
477
iShares US Energy ETF
IYE
$1.8B
| $179K | ﹤0.01% |
4,055
| – | – |
2022 Q1
7 quarters
|
|
478
Atlanta Braves Holdings Series B
BATRK
$3.22B
| $178K | ﹤0.01% |
4,463
| – | – |
2022 Q1
7 quarters
|
|
479
Regency Centers
REG
$13.4B
| $178K | ﹤0.01% |
2,600
| – | – |
2023 Q2
2 quarters
|
|
480
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.9B
| $178K | ﹤0.01% |
+3,000
| New | +$173K |
2023 Q4
0 quarters
|
|
481
Allstate Corp 5.100% Fixed-To-Floating Rate Subordinated Debentures due 2053
ALL.PRB
$509M
| $177K | ﹤0.01% |
6,855
| – | – |
2021 Q4
8 quarters
|
|
482
Lamb Weston
LW
$7.41B
| $176K | ﹤0.01% |
1,628
-40
| -2% | -$3.85K |
2023 Q2
2 quarters
|
|
483
Invesco Financial Preferred ETF
PGF
$593M
| $175K | ﹤0.01% |
11,950
| – | – |
2023 Q2
2 quarters
|
|
484
Nutrien
NTR
$32.9B
| $174K | ﹤0.01% |
3,051
| – | – |
2022 Q1
7 quarters
|
|
485
Toronto Dominion Bank
TD
$199B
| $173K | ﹤0.01% |
2,681
| – | – |
2022 Q1
7 quarters
|
|
486
State Street Financial Select Sector SPDR ETF
XLF
$51.8B
| $173K | ﹤0.01% |
4,590
-3,158
| -41% | -$109K |
2013 Q2
42 quarters
|
|
487
VF Corp
VFC
$6.86B
| $172K | ﹤0.01% |
9,003
-22,350
| -71% | -$383K |
2013 Q2
42 quarters
|
|
488
Match Group
MTCH
$10.7B
| $170K | ﹤0.01% |
4,615
| – | – |
2023 Q2
2 quarters
|
|
489
WisdomTree India Earnings Fund ETF
EPI
$1.83B
| $169K | ﹤0.01% |
4,100
| – | – |
2022 Q1
7 quarters
|
|
490
Veeva Systems
VEEV
$51.6B
| $169K | ﹤0.01% |
+870
| New | +$164K |
2023 Q4
0 quarters
|
|
491
Invesco Water Resources ETF
PHO
$1.96B
| $165K | ﹤0.01% |
2,700
| – | – |
2022 Q1
7 quarters
|
|
492
lululemon athletica
LULU
$11.6B
| $163K | ﹤0.01% |
320
+44
| +16% | +$19K |
2022 Q1
7 quarters
|
|
493
Ecolab
ECL
$80.8B
| $162K | ﹤0.01% |
812
| – | – |
2013 Q2
42 quarters
|
|
494
Chemed
CHE
$6.75B
| $161K | ﹤0.01% |
275
| – | – |
2022 Q1
7 quarters
|
|
495
Entergy
ETR
$50.2B
| $161K | ﹤0.01% |
3,200
| – | – |
2023 Q2
2 quarters
|
|
496
OGE Energy
OGE
$9.8B
| $159K | ﹤0.01% |
4,553
| – | – |
2022 Q1
7 quarters
|
|
497
1st Source
SRCE
$2.08B
| $159K | ﹤0.01% |
2,850
| – | – |
2022 Q1
7 quarters
|
|
498
State Street Industrial Select Sector SPDR ETF
XLI
$30.2B
| $159K | ﹤0.01% |
1,390
+735
| +112% | +$77.1K |
2022 Q1
7 quarters
|
|
499
Boston Properties
BXP
$9.43B
| $158K | ﹤0.01% |
2,163
-300
| -12% | -$17.7K |
2013 Q2
42 quarters
|
|
500
Darden Restaurants
DRI
$24.7B
| $158K | ﹤0.01% |
962
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.